intellectual property


Despite seed concerns, CPTPP study to proceed
Thai farmers and civil society organisations vented their concerns about the impact of the new pact's IP chapter that prevents them from saving and reusing seeds that contain patented plant material.
Un accord de libre-échange Suisse-Indonésie serait à bout touchant
L'Indonésie n’exige plus l’abolition de droits de douane à l’importation de son huile de palme, produit contesté en Suisse, et accepte des règles strictes en matière de propriété intellectuelle.
Extended monopolies on biologic drugs – A warning to developing countries
The United States has throughout history been the principal demandeur of maximalist intellectual property, backed by a powerful pharmaceutical lobby.
RCEP talks: India manages major breakthrough
New Delhi won't not take additional commitment on intellectual property rights beyond the TRIPS agreement it has already accepted at the WTO; investor-state dispute settlement (ISDS) mechanism only for limited sectors.
NAFTA deal close, but obstacles remain
US and Canada officials continue to meet but there are three key issues to resolve: dairy, intellectual property, dispute settlement.
New NAFTA could include tough intellectual property laws that Canada fought against in TPP
The new trade deal reached between the US and Mexico contains a myriad of rules and tariffs, and among them include tougher rules on copyright and intellectual property.
Trade agreements privatising biodiversity outside the WTO: 2018 update
FTAs often oblige countries to adopt or implement the UPOV convention, what some call "Monsanto laws".
Italy threatens to bring down EU-Canada free trade deal
Citing farmers’ complaints, antiestablishment government vows to seek parliamentary veto, which would annul pact for all partners
Trade deals putting health at risk
A leaked draft of the negotiating text has revealed some proposed harmful intellectual property provisions that could undermine access to price-lowering, generic medicines, and thus, life-saving treatment to millions of people.
The myth behind health and trade agreements – Q&A with Othoman Mellouk
Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade.